ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2276

Patient Reported Impact of Lupus on Quality of Life

Beth Schneider, MyHealthTeam, San Francisco, CA

Meeting: ACR Convergence 2023

Keywords: Access to care, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Research was undertaken to better understand how people living with lupus describe its sum total impact on their lives including work, challenges with relationships and its toll on mental health.

Methods: In August 2022, an email invitation to an online survey was sent to US members of MyLupusTeam, a social network of over 218,000 members. In total, 676 members diagnosed with systemic lupuserythematosus completed the 31-question survey regarding experiences with lupus and impact of the disease on everyday life.

Results: The far-reaching impact of lupus was evident in that most reported that lupus had a negative impact on overall quality of life (91%), interferes with their social life (84%), disrupts education/work (78%), and negatively impacts family relationships (66%). These lupus patients also found it hard to do everyday chores (89%) and hard to get around physically (79%). In total, only 7% felt their lupus related health was excellent or very good. “The pain that I have means I can’t do anything.”The emotional toll of lupus manifested in feeling stressed (88%), anxious/depressed (83%) or judged by others (63%). In fact, a large number indicated depression (52%), or anxiety (55%) as diagnosed comorbidities. “Visible symptoms appear on our faces or bodies that cause us to feel so low and embarrassed to show our faces in public.” Despite the many obstacles, respondents were proactive in managing lupus.Most were able to stay on their prescribed medications (83%). And only 12% are not on any medication to treat lupus and its symptoms.However, 32% struggled to afford their medical expenses and these patients were much more likely be in poor health (75% versus 55% among those who could easily afford their medications).

Conclusion: Understanding the physical, emotional, and quality of life impact of lupus, can help rheumatologists provide a more holistic approach to treating lupus patients. This includes listening to patient concerns and addressing the symptoms of lupus, including pain, depression, and fatigue, and not just disease progression. Importantly, by addressing the mental health aspects of lupus, rheumatologists can help create better health outcomes, including effective self-care regimens and an improved quality of life.

Supporting image 1

Impact of Lupus on Quality of Life

Supporting image 2

Impact of Lupus on Mental Health


Disclosures: B. Schneider: None.

To cite this abstract in AMA style:

Schneider B. Patient Reported Impact of Lupus on Quality of Life [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/patient-reported-impact-of-lupus-on-quality-of-life-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-impact-of-lupus-on-quality-of-life-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology